Arsenic Trioxide in Treating Patients With Refractory or Relapsed Chronic Lymphocytic Leukemia

NCT00006090 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped No enrollment.

Conditions

Leukemia

Interventions

DRUG: arsenic trioxide

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]